Obinutuzumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Genentech brand Hoffmann-La Roche brand owl:NamedIndividual Therapeutic monoclonal antibody Monoclonal antibody for tumors Drug granted breakthrough therapy designation
rdfs:label	Obinutuzumab
owl:sameAs	dbr:Obinutuzumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Roche http://en.wikipedia.org/wiki/Genentech http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/CD20 http://en.wikipedia.org/wiki/Category:Genentech_brands http://en.wikipedia.org/wiki/Category:Hoffmann-La_Roche_brands http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors http://en.wikipedia.org/wiki/Rituximab
skos:prefLabel	Obinutuzumab
skos:altLabel	Gazyva obinutuzumab
clgo:alternativeName	Gazyva, Gazyvaro
clgo:casNumber	949142-50-1
clgo:drugbank	DB08935
clgo:fdaUniiCode	O43472U9X8
clgo:kegg	D09321
is clgo:product of	Genentech

About: clgr:Obinutuzumab